$25.9 Million is the total value of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's 76 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PEP | Exit | PEPSICO INC | $0 | – | -20 | -100.0% | -0.01% | – |
| BA | Exit | BOEING CO | $0 | – | -6 | -100.0% | -0.01% | – |
| IWP | Exit | ISHARES TR RUSSELL MIDCAP GROWTH INDetfs | $0 | – | -224 | -100.0% | -0.06% | – |
| CIM | Exit | CHIMERA INVESTMENT CORP | $0 | – | -3,000 | -100.0% | -0.14% | – |
| INSW | Exit | INTERNATIONAL SEAWAYS INC | $0 | – | -3,000 | -100.0% | -0.14% | – |
| FGEN | Exit | FIBROGEN, INC | $0 | – | -1,133 | -100.0% | -0.15% | – |
| RETA | Exit | REATA PHARMACEUTICALS INC | $0 | – | -5,322 | -100.0% | -0.40% | – |
| IVZ | Exit | INVESCO LTD | $0 | – | -5,900 | -100.0% | -0.50% | – |
| MGEN | Exit | MIRAGEN THERAPEUTICS INC | $0 | – | -105,465 | -100.0% | -2.31% | – |
| GMOLQ | Exit | GENERAL MOLY INC | $0 | – | -2,922,831 | -100.0% | -2.62% | – |
| WPZ | Exit | WILLIAMS PARTNERS LPlp - public equity | $0 | – | -172,732 | -100.0% | -16.09% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEXAS INSTRUMENTS INC | 41 | Q3 2023 | 31.2% |
| PORTLAND GENERAL ELECTRIC CO | 38 | Q3 2023 | 0.0% |
| LEXICON PHARMACEUTICALS INC | 33 | Q3 2023 | 1.7% |
| AEGLEA BIOTHERAPEUTICS INC | 27 | Q2 2023 | 11.0% |
| APOLLO ENDOSURGERY INC | 24 | Q1 2023 | 5.6% |
| PLX PHARMA INC | 23 | Q1 2023 | 1.7% |
| VANGUARD MSCI EMERGING MKTS | 22 | Q2 2019 | 10.3% |
| VANGUARD ENERGY ETF | 22 | Q2 2019 | 8.7% |
| VANGUARD S&P 500 ETF | 21 | Q3 2023 | 11.8% |
| VANGUARD MSCI EAFE ETF | 20 | Q2 2019 | 13.1% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Taysha Gene Therapies, Inc. | September 24, 2021 | 1,156,255 | 3.0% |
| ZIOPHARM ONCOLOGY INC | February 12, 2016 | 9 | 0.0% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-06-17 |
| 4 | 2024-06-12 |
| 4 | 2024-06-07 |
| 4/A | 2024-05-14 |
| 4 | 2024-05-01 |
| 3 | 2024-04-30 |
| 13F-HR | 2024-04-30 |
| 144 | 2024-04-29 |
| SC 13G | 2024-03-05 |
| 13F-HR | 2024-02-28 |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.